Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Xue B, Robinson RC
Marin Vrady of the Institute of Parasitology, Slovak Academy of Sciences for providing H
IV dosing in clinical practice varies based on indication, patient health status, and treatment goals
Introduction Cardiovascular diseases (CVDs) are the leading cause of death worldwide and rising health care costs [1]
At Phase II enrollment, participants were randomly assigned to one of two intervention sequences (pomegranate followed by placebo, or placebo followed by pomegranate) (Figure 2)
US$ 23.74
US$ 21.05
US$ 29.62
